Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Shree Ganesh Remedies Ltd
Score 48/100• Decent
Shree Ganesh Remedies Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and market sentiment.
Company’s Health97/100
Valuation 40/100 · PB 3.9585
Technical Avoid
1M -6.545% 6M -28.682% 1Y -40.585%
Confidence100%
Low leverage (D/E)No promoter pledge
#181
View details ➜
S
Saroja Pharma Industries India Ltd
Score 48/100• Risky
Saroja Pharma Industries presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health69/100
Valuation 80/100 · PB 1.1026
Technical Avoid
1M -4.485% 6M 2.748% 1Y -23.008%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#182
View details ➜
S
Sanofi Consumer Healthcare India Ltd
Score 48/100• Decent
Sanofi Consumer Healthcare India Ltd shows potential but faces challenges in profitability and execution risks.
Company’s Health100/100
Valuation 20/100 · PB 38.9513
Technical Avoid
1M 0.248% 6M -9.44% 1Y -5.895%
Confidence100%
Low leverage (D/E)No promoter pledge
#183
View details ➜
M
Marksans Pharma Ltd
Score 48/100• Decent
Marksans Pharma Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health90/100
Valuation 40/100 · PB 3.529
Technical Avoid
1M -0.431% 6M -25.424% 1Y -37.565%
Confidence100%
Low leverage (D/E)No promoter pledge
#184
View details ➜
L
Link Pharmachem Ltd
Score 48/100• Risky
Link Pharmachem Ltd presents a risky investment opportunity due to inconsistent growth, profitability concerns, and high valuation metrics compared to peers.
Company’s Health46/100
Valuation 80/100 · PB 1.1224
Technical Avoid
1M -8.089% 6M -15.187% 1Y -22.065%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#185
View details ➜
L
Lincoln Pharmaceuticals Ltd
Score 48/100• Decent
Lincoln Pharmaceuticals shows potential but faces challenges in profitability and market sentiment.
Company’s Health83/100
Valuation 80/100 · PB 1.4101
Technical Avoid
1M -9.435% 6M -20.849% 1Y -48.539%
Confidence100%
Low leverage (D/E)No promoter pledge
#186
View details ➜
I
Influx Healthtech Ltd
Score 48/100• Risky
Influx Healthtech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health100/100
Valuation 20/100 · PB 14.4954
Technical Momentum
1M 29.136% 6M 79.358% 1Y 79.358%
Confidence100%
Low leverage (D/E)No promoter pledge
#187
View details ➜
R
Rajnish Wellness Ltd
Score 48/100• Risky
Rajnish Wellness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health54/100
Valuation 100/100 · PB 0.7842
Technical Avoid
1M -16.456% 6M -27.778% 1Y -63.483%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#188
View details ➜
R
Raaj Medisafe India Ltd
Score 48/100• Risky
The stock presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns.
Company’s Health84/100
Valuation 40/100 · PB 3.2947
Technical Avoid
1M -10.186% 6M -15.476% 1Y -23.352%
Confidence100%
No promoter pledgeDecent revenue growth
#189
View details ➜
Q
Qualitek Labs Ltd
Score 48/100• Risky
Qualitek Labs Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health92/100
Valuation 20/100 · PB 5.023
Technical Avoid
1M -4.878% 6M 39.373% 1Y 31.579%
Confidence100%
No promoter pledge
#190
View details ➜
Q
QMS Medical Allied Services Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health91/100
Valuation 80/100 · PB 1.6647
Technical Avoid
1M -1.214% 6M 4.606% 1Y -17.612%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#191
View details ➜
M
Mohini Health & Hygiene Ltd
Score 48/100• Risky
Mohini Health & Hygiene Ltd presents several risks, particularly in profitability and market sentiment, making it a risky investment at this time.
Company’s Health63/100
Valuation 100/100 · PB 0.7181
Technical Avoid
1M -15.49% 6M -30.399% 1Y -18.164%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#192
View details ➜
M
Maitreya Medicare Ltd
Score 48/100• Risky
Maitreya Medicare Ltd shows potential in a growing sector, but significant risks and inconsistencies in performance make it a risky investment.
Company’s Health74/100
Valuation 20/100 · PB 5.0536
Technical Avoid
1M -2.778% 6M -14.901% 1Y -27.622%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#193
View details ➜
K
Kopran Ltd
Score 48/100• Risky
Kopran Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
Company’s Health73/100
Valuation 80/100 · PB 1.2189
Technical Avoid
1M -18.93% 6M -35.046% 1Y -36.459%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#194
View details ➜
K
KOBO Biotech Ltd
Score 48/100• Risky
KOBO Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health41/100
Valuation 100/100 · PB -0.0426
Technical Avoid
1M -26.014% 6M -10.196% 1Y -36.034%
Confidence100%
No promoter pledgeReasonable PB valuation
Thin margins
#195
View details ➜
Showing 181 to 195 of 260 (18 Pages)